slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 218,491-218,520
Pages 10,126
Rows per page 30
Component
218,491-218,520 of 303,780
30
Includes reconciliations for equity and assets, as well as comparative GAAP and non-GAAP performance ratios.New York Community Bancorp | Results Presentation Deck | 31 slides · New York Community Bancorp
Conference presentation Investor relations 1 hit
31
New York Community Bancorp | Results Presentation Deck | 31 slidesNew York Community Bancorp | Results Presentation Deck | 31 slides · New York Community Bancorp
Conference presentation Investor relations 1 hit
01
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
03
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses a timeline-style layout to represent drug development stages.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem1 hit
06
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
07
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Solution1 hit
12
The slide uses a split-column layout to contrast the completed Phase 1a with the active Phase 1b.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size1 hit
13
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
14
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
15
The visualization is a standard kinome tree map used in pharmaceutical research to demonstrate drug selectivity.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
19
The slide presents preclinical data supporting the efficacy of NXP900 in combination therapies.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses a chevron-style list layout to categorize highlights.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
23
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
02
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Attention1 hit
03
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses brand-specific imagery (Oatly) to set a casual, unconventional tone for the CEO update.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Attention1 hit
05
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a three-column layout to present market size, financial targets, and corporate mission.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Need1 hit
07
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Need1 hit
08
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Need1 hit
09
The chart uses a waterfall-style visual to show the reduction in SG&A + R&D expenses.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
Slide 13 of a presentation deck.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The slide uses a before-after framework to show product expansion and a bar chart to show market share growth in the UK.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit